Korkmaz-İçöz, S., Radovits, T., & Szabó, G. (2018). Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure. British journal of pharmacology, 175(2), . https://doi.org/10.1111/bph.13749
Chicago-Zitierstil (17. Ausg.)Korkmaz-İçöz, Sevil, Tamás Radovits, und Gábor Szabó. "Targeting Phosphodiesterase 5 as a Therapeutic Option Against Myocardial Ischaemia/reperfusion Injury and for Treating Heart Failure." British Journal of Pharmacology 175, no. 2 (2018). https://doi.org/10.1111/bph.13749.
MLA-Zitierstil (9. Ausg.)Korkmaz-İçöz, Sevil, et al. "Targeting Phosphodiesterase 5 as a Therapeutic Option Against Myocardial Ischaemia/reperfusion Injury and for Treating Heart Failure." British Journal of Pharmacology, vol. 175, no. 2, 2018, https://doi.org/10.1111/bph.13749.